A Phase 2B trial of 89 adult patients conducted by Melbourne-based MindBio Therapeutics, investigating the effects of microdosing LSD in the treatment of major depressive disorder, found that the psychedelic was actually outperformed by a placebo. Across an eight-week period, symptoms were gauged using the Montgomery-Åsberg Depression Rating Scale (MADRS), a widely recognized tool for the clinical evaluation of depression.
The study has not yet been published. But MindBio’s CEO Justin Hanka recently released the top-line results on his LinkedIn, eager to show that his company was “in front of the curve in microdosing research.”
On LinkedIn. Did they also go on a bizarre rant?
Why would you publish results to a site that nobody can see unless they want all their data mined by microsoft? Fuck LinkedIn.
Stimulants in proper doses seem to be able to help with depression. Some studies show adderall can help depression too.
What about a pot of coffee with a sheet of LSD mixed into it? Surely the therapeutic effects must work wonders
A cup of LSD and depression is not a problem anymore.
Microdosing *what? Stupid headline making me click to see the comments.
Why not both?
